City of Hope scientists are devoted to unraveling the cellular intricacies of how diabetes occurs and developing leading-edge therapies.   At the recent 81st Scientific Sessions of the American Diabetes...

The need for innovative science to address type 1 diabetes only grows more urgent. The JDRF counts 1.6 million people living with the disease in the U.S., and that number is increasing...

Jodi Cruz never expected to be this healthy, or this lucky, or possibly even alive, by now.   That’s because the 45-year-old mother of three from Irvine, California, had struggled...

CONTACT Letisia Marquez 626-476-7593 lemarquez@coh.org   The investigational vaccine is the first-of-its-kind for type 1 diabetes to be tested in the United States and showed positive results in an early...

Biochemist Charles Brenner, Ph.D., has joined City of Hope to lead the nation’s first research department focused on the intersection between cancer and diabetes. He is also the inaugural holder...

Imagine there’s a “boiling point” for cancer — an exact point at which a normal cell becomes malignant, just as water becomes vapor at 212 degrees Fahrenheit. Once we discovered...

At a recent virtual symposium — “Diabetes and Cancer Interface: Connecting the Dots” — City of Hope gynecologic cancer expert Lorna Rodríguez-Rodriguez, M.D., Ph.D., issued a call to arms of...

Debbie Thurmond, Ph.D. Debbie Thurmond, Ph.D., studies proteins that have a long biological history.   “They’re an old gene family, ancestral,” said Thurmond, holder of City of Hope’s Ruth B. & Robert...

During her more than 30 years at City of Hope, Joyce Niland, Ph.D., the Estelle & Edward Alexander Chair in Information Sciences, has helped design, build and operate City of...

Imagine there’s a “boiling point” for cancer — an exact point at which a normal cell becomes malignant, just as water becomes vapor at 212 degrees Fahrenheit. Once we discovered...